Company profile
Ticker
CLCD
Exchange
Employees
Location
Fiscal year end
Industry (SIC)
Former names
Colucid Pharmaceuticals Inc
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-12B
Securities registration termination
13 Mar 17
EFFECT
Notice of effectiveness
3 Mar 17
POS AM
Prospectus update (post-effective amendment)
2 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Mar 17
25-NSE
Exchange delisting
1 Mar 17
8-K
Completion of Acquisition or Disposition of Assets
1 Mar 17
SC 14D9/A
Tender offer solicitation (amended)
1 Mar 17
SC TO-T/A
Third party tender offer statement (amended)
1 Mar 17
SC 14D9/A
Tender offer solicitation (amended)
14 Feb 17
Latest ownership filings
SC 13D/A
CoLucid Pharmaceuticals, Inc.
20 Apr 17
SC 13D/A
CoLucid Pharmaceuticals, Inc.
2 Mar 17
4
Alison Frances Lawton
1 Mar 17
4
Matthew D Dallas
1 Mar 17
4
Linda C. Hogan
1 Mar 17
4
Raymond Skwierczynski
1 Mar 17
4
Thomas P. Mathers
1 Mar 17
4
ARTHUR M PAPPAS
1 Mar 17
4
Marvin L White
1 Mar 17
4
Bernice Kuca
1 Mar 17
Institutional ownership, Q3 2019
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|